protocol – Page 224 – Communicable Diseases Research

How Frequently Do We Touch Facial T-Zone: A Systematic Review

Review

Published on 2020-07-062022-10-27
Journal: Annals of Global Health [Category] Coronavirus, SARS,

Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation

Rapid Communication

Published on 2020-07-052022-10-28
Journal: Virus Evolution [Category] COVID-19,

Public Health Academic Alliance for COVID-19 Response: The Role of a National Medical Task Force in Puerto Rico

Perspective

Published on 2020-07-052022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic

Observational Study

Published on 2020-07-042022-10-04
Journal: World Journal of Urology [Category] SARS, 임상,

Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial

Letter

Published on 2020-07-032022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] age airway Alpha anticipated approved assistant benefit Blinding Care carried Chest Chest physiotherapy children Complication coordinating center COVID-19 Critically ill dissemination element expiratory File healthcare worker hypertonic Hypoxemia ICU ICUs independent intensive care intensive care unit intervention arm invasive ventilation management mechanical ventilation mechanically ventilated patient Mortality nasal nasal mask non-inferiority design Non-invasive non-invasive ventilation number objective Oscillation outcome Oxygenation pandemic participant patients with COVID-19 pediatric performed Physiotherapist pilot multicenter positive positive airway pressure Positive end-expiratory pressure positive pressure ventilation Pragmatic Primary outcome protocol provided random Randomized Randomized controlled trial Randomly recruited recruitment reduce Research responsible Sample size sealed Study protocol treatment for COVID-19 ventilator virus vital signs Volume vomiting website with COVID-19
[DOI] 10.1186/s13063-020-04533-6 PMC 바로가기 [Article Type] Letter

The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-032022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Analysis approved baseline bleeding blinded Blinding block Blood China Chinese clinical Cognitive impairment Complete conducted contraindication control group Controlled clinical trial coronavirus COVID-19 curative dissemination Effect element evaluate evaluator exclusion criteria experimental group ground glass healthcare worker Hypothesis ICU include inclusion criteria Inflammation Intervention lactating women Lungs management manifestation mechanical ventilation multiple organ failure Mycoplasma novel nucleic acid test number objective outcome parallel group participant patchy pathogen Patient performed Pharyngeal swab Pneumonia positive primary outcome measure protocol randomised randomised controlled trial Randomized reached receiving Registered reported required Respiratory failure Sample size secondary outcome measure serum analysis Shock SIRS Standard status Study protocol Symptoms therapeutic effect therapy Tongji Hospital Treatment Trial Ultra short-wave diathermy underlying diseases vital sign website Wuhan
[DOI] 10.1186/s13063-020-04534-5 PMC 바로가기 [Article Type] Letter

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-022022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] active treatment phase Amiodarone anticipated Arm ARMS assessment baseline blinded Block randomisation block size Blood Group Breastfeeding Cambridge Care Chemoprophylaxis Chloroquine Chronic kidney disease ciprofloxacin clarithromycin clinical clinical testing Compliance Contact coronavirus disease COVID-19 COVID-19 case COVID-19 disease COVID-19 disease severity COVID-19 infection COVID-19 patients criteria current cyclosporin Daily Daily-dosing Date Day deficiency defined described determine diagnosed with COVID-19 Diagnosis digoxin disease dissemination dose dosed element enrolled enrolment epilepsy EU Clinical Trial EudraCT evaluated Factor File fluconazole Follow-up foundation frontline healthcare workers G6PD Genetic Glucose-6-phosphate halofantrine HCQ healthcare Healthcare workers heart failure hospital Hydroxychloroquine hypersensitivity reaction increase Infection Intervention investigator Laboratory Liver disease maintenance Matched mefloquine moxifloxacin National Health Service NHS number objective oral outcome participant Participants Patient patients with COVID-19 pharmacokinetic phase Placebo placebo tablet placebo-controlled trial porphyria positive COVID-19 positive individual Positive test Praziquantel predicted Prevent problem prochlorperazine protocol randomised randomised controlled trial recruited recruitment regimen Registered reported Research Retinal disease Sample size Secondary objective serology serum biomarker Standard statistical analysis status Stratification stratified Study protocol susceptibility symptoms onset syndrome table Tablet tablets time Treatment treatment period Trial Trust university Variation website Weekly Weekly-dosing work
[DOI] 10.1186/s13063-020-04543-4 PMC 바로가기 [Article Type] Letter

Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial

Letter

Published on 2020-07-022022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 1:1 aetiology agreement allocation Anosmia anticipated Arm ARMS Asymptomatic automatically Barcelona blinded block randomization Cardiac pathology change characterized chills clinical Clinical course clinical trial close contact collected Compound Concomitant conducted confirmed COVID-19 case Contact cough Course COVID-19 COVID-19 disease COVID-19 disease severity CRF criteria delivery determine diarrhoea dissemination double-blind Dyspnoea ECDC Effect Efficacy Efficacy and safety element EudraCT evaluate evaluate the effect Fever FIVE gestation global health HCQ headache history hospital Hospitalization Hydroxychloroquine hypersensitivity inclusion criteria intervention study investigator Liver disease Mild mild symptoms Mortality multicentre nasopharyngeal number objective oropharyngeal swab outcome packaged Pain participant Patient PCR PCR-confirmed Placebo placebo controlled trial placebo-controlled Pregnancy pregnant pregnant women prenatal Prevent Primary outcome progression protocol randomised randomised controlled trial Randomized receive recruited recruitment reducing Registered risk Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 viral shedding status stratified study group study participant Study protocol subsequent Symptom symptomatic syndrome Tablet Tolerability Transmission Treatment treatment group Trial Two-arm uterine website women
[DOI] 10.1186/s13063-020-04557-y PMC 바로가기 [Article Type] Letter

Acupuncture for breathlessness in COVID-19 A protocol for systematic review and meta-analysis

3800

Published on 2020-07-022022-10-30
Journal: Medicine [Category] COVID-19, SARS,

The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms

Protocol

Published on 2020-07-022022-10-31
Journal: JMIR Public Health and Surveillance [Category] COVID-19,

[키워드] accelerate Accessibility acute respiratory syndrome adaptive clinical trials analyses Analysis approaches approval benefit Care clinical clinical trial clinical trials clinical trials as a topic collected college communicable Community contribute coronavirus coronavirus disease COVID-19 data extraction data set data sets Digital disease incidence Disease surveillance dissemination drug effective episode European Extended facilitate facilitated feasibility fixed food General practice general practitioner General practitioners Health Health Service Host Identifier informatics initial International interoperability lockdown medical record systems, computerized Metadata National objective office Older ontologies Oxford pandemic participant partnership Patient care platform positive response Practice primary care Primary Health Care protocol Public Health England public health surveillance recorded Regulatory report Repository Research Result SARS-CoV-2 secure sentinel sentinel surveillance serology severe acute respiratory syndrome coronavirus 2 Statistics Support Surveillance Swab Trial United Kingdom Volume
[DOI] 10.2196/19773 PMC 바로가기 [Article Type] Protocol